Join
Live feed
·
INSIDERFilingvia Quantisnow
TFF Pharmaceuticals Inc. logo

SEC Form 4: Coleman Kirk Allen bought $7,553 worth of shares (1,675 units at $4.51), increasing direct ownership by 84% to 3,675 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TFFP (TFF Pharmaceuticals Inc.) and more on Quantisnow.